SPEN and B-cell chronic lymphocytic leukemia: Moreover, non-mutational NOTCH1 activation found in ~50% of CLL cells lacking a NOTCH1 mutation implies that even an extended panel including SPEN, SF3B1, FBXW7 and MED12 mutations will neither be sufficient to identify all patients with abnormally strong NOTCH1 signalling.